Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 253 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Elacestrant in ESR1-mutant, Endocrine-Responsive Metastatic Breast Cancer: Should Health Authorities Consider Post Hoc Data to Inform Priority Access
C. Valenza,D. Trapani, F. -c. Bidard, J. Gligorov, J. Cortes, N. Turner, F. Dalenc, F. Penault-Llorca, G. Freyer,M. Arnedos, C. Villanueva, S. Loibl, B. Pistilli, G. Curigliano
ESMO OPEN（2024）
Cited0Views0WOSBibtex
0
0
ESR1 CTDNA Testing in HR+/HER2 Metastatic Breast Cancer: A Real-World Perspective from a Referral Laboratory
Konstantinos Venetis,Dario Trapani, Riccardo Adorisio,Alberto Ranghiero, Grazia Castellano, Virginia Peruzzo,Davide Vacirca,Giuseppe Curigliano, Nicola Fusco, Elena Guerini Rocco
The Journal of Liquid Biopsy (2024): 100229
Cited0Views0Bibtex
0
0
Why Effect Sizes Are Systematically Larger for Progression-Free Survival Than Overall Survival in Cancer Drug Trials: Prognostic Scores As a Way Forward
Luca Locher, Miquel Serra-Burriel,Dario Trapani, Emanuel Nussli, Kerstin N Vokinger
European journal of cancer (Oxford, England 1990) (2024): 115106-115106
Cited0Views0WOSBibtex
0
0
152P Inflammatory breast cancer (IBC) in low and middle-income countries (LMICs): Knowledge, and practice patterns - The BRIDGES study
I.M. Schlam,K. Hirko, D. Shveid Gerson, I. Abuali, S. Sewaralthahab, F. Nakhils, A. Hazra,C.G. Lengyel,S.C. Altuna, S. Hussain,F.U. Seid, S.J. Nidhamalddin, A.O. Odhiambo,J.P. Leone, O. Metzger, W. Chen,G. Curigliano,S.M. Tolaney,F. Lynce,D. Trapani
ESMO Open (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 252

#Citation: 2868

H-Index: 23

G-Index: 51

Sociability: 7

Diversity: 0

Activity: 9

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn